双联抗血小板-话题@MedSci

#双联抗血小板#

38篇内容 | 2038人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2186961, encodeId=323b218696168, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a> <a href='/topic/show?id=ce09410911e' target=_blank style='color:#2F92EE;'>#国际卒中大会#</a>, objectTitle=ISC 2024：微小卒中患者的双联抗血小板疗法与阿替普酶如何选择？, objectType=article, longId=813155, objectId=a43e813155bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240211/1707644923073_2299762.png, objectUrl=/article/show_article.do?id=a43e813155bb, replyNumber=0, likeNumber=62, createdTime=2024-02-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a43e813155bb, moduleTitle=ISC 2024：微小卒中患者的双联抗血小板疗法与阿替普酶如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a43e813155bb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2009542, encodeId=e739200954214, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性, objectType=article, longId=727521, objectId=51cae2752113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51cae2752113, replyNumber=0, likeNumber=108, createdTime=2023-04-20, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51cae2752113, moduleTitle=双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51cae2752113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009541, encodeId=bc1f2009541a7, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Neurology：双联抗血小板治疗2周后应该更换为联合西洛他唑的双抗？, objectType=article, longId=724281, objectId=7bc8e242810c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bc8e242810c, replyNumber=0, likeNumber=98, createdTime=2022-05-09, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bc8e242810c, moduleTitle=Neurology：双联抗血小板治疗2周后应该更换为联合西洛他唑的双抗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bc8e242810c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009540, encodeId=addf20095403d, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=皮瓣移植围手术期是否应该停止双联抗血小板治疗?, objectType=article, longId=293780, objectId=dc89293e80d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc89293e80d8, replyNumber=0, likeNumber=103, createdTime=2022-06-30, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc89293e80d8, moduleTitle=皮瓣移植围手术期是否应该停止双联抗血小板治疗?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc89293e80d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009543, encodeId=492820095430c, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=【当抗栓遇见出血】急性冠脉综合征的双联抗血小板治疗以及出血并发症的防治, objectType=article, longId=256815, objectId=fdc6256815f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdc6256815f9, replyNumber=0, likeNumber=76, createdTime=2022-04-13, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdc6256815f9, moduleTitle=【当抗栓遇见出血】急性冠脉综合征的双联抗血小板治疗以及出血并发症的防治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdc6256815f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009539, encodeId=985520095393f, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=DAPT的出血管理策略——冠心病双联抗血小板治疗中国专家共识解读, objectType=article, longId=213596, objectId=a62a2135966f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62a2135966f, replyNumber=0, likeNumber=74, createdTime=2021-07-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62a2135966f, moduleTitle=DAPT的出血管理策略——冠心病双联抗血小板治疗中国专家共识解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62a2135966f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009536, encodeId=26022009536b2, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%, objectType=article, longId=175408, objectId=68c91e54082a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c91e54082a, replyNumber=0, likeNumber=83, createdTime=2019-08-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c91e54082a, moduleTitle=BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c91e54082a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009538, encodeId=d1b1200953807, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=JAMA Neurol：双联抗血小板严重出血的特点, objectType=article, longId=178093, objectId=c90f1e80933a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c90f1e80933a, replyNumber=0, likeNumber=82, createdTime=2020-01-21, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c90f1e80933a, moduleTitle=JAMA Neurol：双联抗血小板严重出血的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c90f1e80933a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009537, encodeId=43fa200953ea9, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=JAMA N：双联抗血小板严重出血的特点, objectType=article, longId=177992, objectId=3cdb1e799275, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cdb1e799275, replyNumber=0, likeNumber=87, createdTime=2019-08-28, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cdb1e799275, moduleTitle=JAMA N：双联抗血小板严重出血的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cdb1e799275)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009534, encodeId=272e20095346f, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Stroke：双联抗血小板的更佳持续时间到底多久？, objectType=article, longId=167355, objectId=7e9c16e35593, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9c16e35593, replyNumber=0, likeNumber=89, createdTime=2019-10-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9c16e35593, moduleTitle=Stroke：双联抗血小板的更佳持续时间到底多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9c16e35593)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009535, encodeId=e479200953572, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=复杂冠脉介入术后，长期单用替格瑞洛优于标准双联抗血小板治疗, objectType=article, longId=167365, objectId=c4a616e3654b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a616e3654b, replyNumber=0, likeNumber=115, createdTime=2019-06-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a616e3654b, moduleTitle=复杂冠脉介入术后，长期单用替格瑞洛优于标准双联抗血小板治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a616e3654b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009531, encodeId=7e6b2009531da, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Neurology：急性缺血性卒中患者双联抗血小板治疗预处理对静脉溶栓的影响, objectType=article, longId=146929, objectId=a91214692938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91214692938, replyNumber=0, likeNumber=77, createdTime=2019-01-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91214692938, moduleTitle=Neurology：急性缺血性卒中患者双联抗血小板治疗预处理对静脉溶栓的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91214692938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009533, encodeId=83932009533f4, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Stroke Vasc Neurol：双联抗血小板治疗的起始时间窗是否可以扩大到72小时？, objectType=article, longId=160978, objectId=cebf1609e889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cebf1609e889, replyNumber=0, likeNumber=91, createdTime=2019-06-12, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cebf1609e889, moduleTitle=Stroke Vasc Neurol：双联抗血小板治疗的起始时间窗是否可以扩大到72小时？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cebf1609e889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009532, encodeId=d5de200953218, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=BMJ：植入药物洗脱支架的ST段抬高心肌梗死患者6个月与12个月双联抗血小板治疗疗效比较, objectType=article, longId=150312, objectId=8a1d15031219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a1d15031219, replyNumber=0, likeNumber=100, createdTime=2018-11-29, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a1d15031219, moduleTitle=BMJ：植入药物洗脱支架的ST段抬高心肌梗死患者6个月与12个月双联抗血小板治疗疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a1d15031219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009527, encodeId=ef7c200952e1f, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Neurology：高敏C反应蛋白水平可预测颅内动脉狭窄患者接受双联抗血小板治疗效果, objectType=article, longId=126437, objectId=97be12643e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97be12643e9e, replyNumber=0, likeNumber=114, createdTime=2018-02-01, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97be12643e9e, moduleTitle=Neurology：高敏C反应蛋白水平可预测颅内动脉狭窄患者接受双联抗血小板治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97be12643e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009529, encodeId=9a3b200952991, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加, objectType=article, longId=134286, objectId=4bf7134286bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bf7134286bd, replyNumber=0, likeNumber=90, createdTime=2018-09-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bf7134286bd, moduleTitle=JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bf7134286bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009526, encodeId=bab120095262e, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Int J Oral Max Surg：双联抗血小板治疗后测定患者拔牙时出血量, objectType=article, longId=113803, objectId=b4541138031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4541138031b, replyNumber=0, likeNumber=72, createdTime=2017-09-28, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4541138031b, moduleTitle=Int J Oral Max Surg：双联抗血小板治疗后测定患者拔牙时出血量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4541138031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009530, encodeId=2d17200953012, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=植入支架后，双联抗血小板时间可以缩短吗？, objectType=article, longId=134856, objectId=bcab13485679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcab13485679, replyNumber=0, likeNumber=98, createdTime=2019-03-22, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcab13485679, moduleTitle=植入支架后，双联抗血小板时间可以缩短吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcab13485679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009528, encodeId=e1222009528a2, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Neurology：双联抗血小板治疗持续时间与出血风险, objectType=article, longId=132875, objectId=78a41328e532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a41328e532, replyNumber=0, likeNumber=84, createdTime=2019-01-26, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a41328e532, moduleTitle=Neurology：双联抗血小板治疗持续时间与出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a41328e532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009523, encodeId=bf762009523e2, content=<a href='/topic/show?id=4f133e56590' target=_blank style='color:#2F92EE;'>#双联抗血小板#</a>, objectTitle=Thromb Haemostasis：12个月和30个月双联抗血小板治疗对死亡率和癌症有何影响？, objectType=article, longId=100326, objectId=5d9410032687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d9410032687, replyNumber=0, likeNumber=76, createdTime=2017-11-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d9410032687, moduleTitle=Thromb Haemostasis：12个月和30个月双联抗血小板治疗对死亡率和癌症有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d9410032687)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

双联抗血小板

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#双联抗血小板# #国际卒中大会#

ISC 2024：微小卒中患者的双联抗血小板疗法与阿替普酶如何选择？

2024-02-11发表于陕西省

仁医06 (审核中...)

前往app查看评论内容

#双联抗血小板#

双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性

2023-04-20

仁医06 (审核中...)

前往app查看评论内容

#双联抗血小板#

Neurology：双联抗血小板治疗2周后应该更换为联合西洛他唑的双抗？

2022-05-09

仁医06 (审核中...)

前往app查看评论内容

#双联抗血小板#

皮瓣移植围手术期是否应该停止双联抗血小板治疗?

2022-06-30

仁医06 (审核中...)

前往app查看评论内容

#双联抗血小板#

【当抗栓遇见出血】急性冠脉综合征的双联抗血小板治疗以及出血并发症的防治

2022-04-13

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

DAPT的出血管理策略——冠心病双联抗血小板治疗中国专家共识解读

2021-07-08

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%

2019-08-23

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

JAMA Neurol：双联抗血小板严重出血的特点

2020-01-21

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

JAMA N：双联抗血小板严重出血的特点

2019-08-28

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Stroke：双联抗血小板的更佳持续时间到底多久？

2019-10-03

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

复杂冠脉介入术后，长期单用替格瑞洛优于标准双联抗血小板治疗

2019-06-06

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Neurology：急性缺血性卒中患者双联抗血小板治疗预处理对静脉溶栓的影响

2019-01-13

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Stroke Vasc Neurol：双联抗血小板治疗的起始时间窗是否可以扩大到72小时？

2019-06-12

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

BMJ：植入药物洗脱支架的ST段抬高心肌梗死患者6个月与12个月双联抗血小板治疗疗效比较

2018-11-29

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Neurology：高敏C反应蛋白水平可预测颅内动脉狭窄患者接受双联抗血小板治疗效果

2018-02-01

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

JAHA：我国≥75岁PCI患者负荷双联抗血小板治疗无临床获益且出血风险增加

2018-09-18

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Int J Oral Max Surg：双联抗血小板治疗后测定患者拔牙时出血量

2017-09-28

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

植入支架后，双联抗血小板时间可以缩短吗？

2019-03-22

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Neurology：双联抗血小板治疗持续时间与出血风险

2019-01-26

tulenzi (审核中...)

前往app查看评论内容

#双联抗血小板#

Thromb Haemostasis：12个月和30个月双联抗血小板治疗对死亡率和癌症有何影响？

2017-11-06

科室
- - 订阅+
  - 更多科室
工具
服务